Rani Therapeutics

company

About

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

Details

Last Funding Type
Series D
Last Funding Money Raised
$39M
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2012
Number Of Employee
51 - 100
Operating Status
Active
Stock Symbol
nasdaq:RANI
Legal Name
Rani Therapeutics, Inc.

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

They developed the RaniPill capsule, which is Rani's novel, proprietary, and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine.

To date, Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability, and bioavailability using the RaniPill capsule. Their development efforts have enabled them to construct an extensive intellectual property portfolio that they believe provides patients with a competitive advantage.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$329.80M
Rani Therapeutics has raised a total of $329.80M in funding over 2 rounds. Their latest funding was raised on Aug 8, 2022 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 8, 2022 Post-IPO Debt $45M Detail
Jul 30, 2021 IPO $73.30M Detail
Dec 10, 2020 Series E $69M Detail
Feb 7, 2018 Series Unknown $53M 9 Bossa Ventures
Cathay Venture
GeneScience Pharmaceuticals
Shire
Detail
Sep 9, 2017 Series D $39M 3 GV Detail

Investors

Number of Lead Investors
Number of Investors
7
17
Rani Therapeutics is funded by 17 investors. Bossa Ventures and Cathay Venture are the most recent investors.
Investor Name Lead Investor Funding Round
Bossa Ventures Yes Series Unknown
Cathay Venture Yes Series Unknown
GeneScience Pharmaceuticals Yes Series Unknown
Shire Yes Series Unknown
Incube Ventures Yes Series A
AstraZeneca Series Unknown
GV Series Unknown
Novartis Series Unknown
Ping An Ventures Series Unknown
Virtus Inspire Ventures Series Unknown

Employee Profiles

Number of Employee Profiles
7
Rani Therapeutics has 7 current employee profiles, including Executive Mir Imran
Executive
Board member
Executive
Executive
Executive